Institutional investors purchased a net $1.1 million shares of DRRX during the quarter ended September 2017, and now own 45.51% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MANGROVE PARTNERS Bought 932.1 Thousand shares of DURECT Corp